Wilson's disease (hepatolenticular degeneration)
- PMID: 1023089
Wilson's disease (hepatolenticular degeneration)
Abstract
Wilson's disease, or hepatolenticular degeneration, is a rare inherited disorder of copper metabolism which usually affects young people. Excess copper accumulates in the tissues, primarily in the liver, brain, and cornea. This copper deposition results in a wide range of hepatic and neurological symptoms, and may produce psychiatric illness. Hepatic involvement often occurs in childhood, while neurological deficits generally are detected at a later age. The disease is inherited in an autosomal recessive fashion. Ocular findings are of particular importance because the corneal copper deposition, forming the Kayser-Fleischer ring,is the only pathognomonic sign of the disease. The structure of the ring and the presence of copper have been well established. An anterior capsular deposition of copper in the lens results in a characteristic sunflower cataract in some of these patients. Other ocular abnormalities have been described but are much less common. The pathogenesis of the disease and the basic genetic defect remain obscure. It is clear that there is excess copper in the tissues, but the mechanism of its deposition is unknown. It is in some way associated with a failure to synthesize the serum copper protein ceruloplasmin normally. Another theory suggests that an abnormal protein with a high affinity for copper may bind the metal in the tissues. The diagnosis may be suggested by the clinical manifestations and confirmed by the presence of a Kayser-Fleischer ring. In the absence of these findings biochemical determinations are necessary. The most important of these are the serum ceruloplasmin, the urinary copper, and the hepatic copper concentration on biopsy. Treatment consists in the administration of the copper chelating agent, penicillamine, and the avoidance of a high copper intake. This usually results in marked clinical improvement if irreversible tissue damage has not occurred. Maintenance therapy for life is necessary in order to continue the negative copper balance. The detection and prophylactic treatment of asymptomatic individuals with the disease is especially important. Seven cases of Wilson's disease have been presented in order to illustrate many of the features which have been discussed, with emphasis on the ocular findings.
Similar articles
-
[The onset of psychiatric disorders and Wilson's disease].Encephale. 2007 Dec;33(6):924-32. doi: 10.1016/j.encep.2006.08.009. Epub 2007 Sep 5. Encephale. 2007. PMID: 18789784 French.
-
Wilson's disease patients with normal ceruloplasmin levels.Turk J Pediatr. 1999 Jan-Mar;41(1):99-102. Turk J Pediatr. 1999. PMID: 10770682
-
Pathophysiology and treatment of Wilson's disease.Clin Pharm. 1991 Nov;10(11):839-49. Clin Pharm. 1991. PMID: 1794220 Review.
-
Ocular manifestations of Wilson's disease in Iran.Trans Ophthalmol Soc U K (1962). 1977 Apr;97(1):18-9. Trans Ophthalmol Soc U K (1962). 1977. PMID: 271391
-
Wilson's disease: a new gene and an animal model for an old disease.J Investig Med. 1995 Aug;43(4):323-36. J Investig Med. 1995. PMID: 7552582 Review.
Cited by
-
Review of the Efficacy and Mechanisms of Traditional Chinese Medicine for Treating Multi-Organ Damage in Wilson's Disease.Drug Des Devel Ther. 2025 Apr 1;19:2453-2471. doi: 10.2147/DDDT.S515123. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40190811 Free PMC article. Review.
-
A 54-year-old man with bilateral symmetrical circular corneal opacities.Digit J Ophthalmol. 2020 Jun 21;26(2):21-26. doi: 10.5693/djo.03.2019.12.001. eCollection 2021 Feb. Digit J Ophthalmol. 2020. PMID: 33867878 Free PMC article. No abstract available.
-
Copper metabolism in American retinitis pigmentosa patients.Br J Ophthalmol. 1978 Mar;62(3):168-71. doi: 10.1136/bjo.62.3.168. Br J Ophthalmol. 1978. PMID: 638109 Free PMC article.